Xiao Xu

USPTO Granted Patents = 56 (Patent Applications = 13)

CIPO Patents = 10 (Patent Applications = 6)

EPO Patents = 12 (Patent Applications = 18)

Average Co-Inventor Count = 4.2

ph-index = 18

Forward Citations = 874(Granted Patents)

Forward Citations (Not Self Cited) = 334(Oct 12, 2025)

Inventors with similar research interests:

Company Filing History:

39 out of 49

Acea Biosciences, Inc.

patents

9 out of 10

Acea Therapeutics, Inc.

patents

5 out of 4,667

Agilent Technologies, Inc.

Hangzhou Acea Pharmaceutical Research Co., Ltd.

patent

7. 1 out of 1

Zhejiang Acea Pharmaceuticals Co., Ltd.

patent

where one patent can have more than one assignee

Years Active: 2002-2024

Loading Chart...

56 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12066428 - Cell-substrate impedance monitoring of cancer cells (2024-08-20),

2. 11987554 - Protease inhibitors as antivirals (2024-05-21),

3. 11906508 - Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution (2024-02-20),

4. 11753373 - Protease inhibitors as antivirals (2023-09-12),

5. 11612602 - Heterocyclic compounds and uses as anticancer agents (2023-03-28),

6. 11604197 - Real time electronic cell sensing systems and applications for cell-based assays (2023-03-14),

7. 11498922 - Pharmaceutical composition comprising N-(3-((2-((3-fluoro-4-(4-methylpiperazin-1-yl phenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)phenylacrylamide (2022-11-15),

8. 11360072 - Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution (2022-06-14),

9. 11346797 - System and method for monitoring cardiomyocyte beating, viability, morphology and electrophysiological properties (2022-05-31),

10. 11007197 - EGFR modulators and uses thereof (2021-05-18),

11. 10799504 - Heterocyclic compounds and uses as anticancer agents (2020-10-13),

12. 10725023 - Method of measuring cell-substrate impedance in living cells to identify compounds affecting receptor tyrosine kinase (RTK) activity and pathways for the treatment of cancer (2020-07-28),

13. 10690677 - Real time electronic cell sensing systems and applications for cell-based assays (2020-06-23),

14. 10620188 - Using impedance-based cell response profiling to identify putative inhibitors for oncogene addicted targets or pathways (2020-04-14),

15. 10596174 - Pyrrolopyrimidine compounds as inhibitors of protein kinases (2020-03-24),

Title: The Innovative Journey of Xiao Xu

Introduction: Xiao Xu, a talented inventor based in San Diego, CA, is known for her groundbreaking contributions to the field of technology and innovation. As a woman in a male-dominated industry, she has defied stereotypes and made a significant impact with her inventive spirit.

Latest Patents: Xiao Xu holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology. Her most recent patent focuses on a revolutionary method for optimizing solar panel efficiency, showcasing her commitment to sustainability and clean energy solutions.

Career Highlights: With a background in engineering and a passion for problem-solving, Xiao Xu has enjoyed a successful career marked by numerous achievements. She has worked for leading tech companies, where she has spearheaded projects that have pushed the boundaries of technological advancement.

Collaborations: Xiao Xu is known for her collaborative nature, often partnering with other inventors, researchers, and industry experts to bring her ideas to life. Through these collaborations, she has been able to leverage diverse perspectives and expertise to create innovative solutions to complex challenges.

Conclusion: Xiao Xu's dedication to innovation, coupled with her relentless drive to make a difference, has solidified her reputation as a trailblazer in the world of technology. Her inventive spirit and commitment to excellence continue to inspire others in the industry and beyond.

This text is generated by artificial intelligence and may not be accurate.